Stocks Health care ZTS
NYSE · Health careZoetis Inc. (ZTS)
Zoetis Inc. brought in $9.5B of revenue over the twelve months to September 30, 2026, up 0.9% from a year earlier. Net income was $2.5B, a net margin of 26.4%. Operating cash flow minus capital spending left $2.3B of free cash flow in fiscal 2025. At September 30, 2026 it held $1.3B in cash against $9B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Zoetis Inc.
- Net worth
- Zoetis Inc. has a market value (market cap) of $34.2B at the latest share price, and shareholders' equity of $3.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $9.5B (+2.3% year on year), with net income of $2.7B. Over the 12 months to September 30, 2026: revenue $9.5B, net income $2.5B.
- Cash flow
- In fiscal 2025 operations brought in $2.9B of cash; after $621M of capital spending, free cash flow was $2.3B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Zoetis Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Zoetis Inc. paid dividends of $2.03 per share in fiscal 2025, a yield of 2.45% at the current price.
What Zoetis Inc. does
Zoetis Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker ZTS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $9.5B | $2.7B | $6.02 | $2.3B |
| 2024 | $9.3B | $2.5B | $5.47 | $2.3B |
| 2023 | $8.5B | $2.3B | $5.07 | $1.6B |
| 2022 | $8.1B | $2.1B | $4.49 | $1.3B |
| 2021 | $7.8B | $2B | $4.27 | $1.7B |
| 2020 | $6.7B | $1.6B | $3.42 | $1.7B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ZTS ranks in Health care
Dividends
Zoetis Inc. paid $2.03 per share in fiscal 2025. At the current price that is a yield of 2.45%. It paid out $889M in cash dividends, 33% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $2.03 | $889M | 33% |
| 2024 | $1.80 | $786M | 32% |
| 2023 | $1.56 | $692M | 30% |
| 2022 | $1.35 | $611M | 29% |
| 2021 | $1.08 | $474M | 23% |
| 2020 | $0.85 | $380M | 23% |
Latest SEC filings
What Zoetis Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 1.3% to $2.4B versus the same quarter last year; diluted EPS $1.44 versus $1.63.
- November 5, 2026
- October 13, 2026
- October 8, 2026
- August 6, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue was flat at $2.5B versus the same quarter last year; diluted EPS $1.65 versus $1.63.
- August 6, 2026
- July 30, 2026Passive stake changed SCHEDULE 13G/A
- June 22, 2026
- May 28, 2026
What is ZTS worth? A DCF from its reported cash flow
Insider trades
What the people running Zoetis Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 30, 2026 | Fuller JulieExecutive Vice President | Exercised options | 799 | - |
| September 30, 2026 | Fuller JulieExecutive Vice President | Shares withheld for tax | 274 | $19.1K |
| August 7, 2026 | Damelio Frank ADirector | Gave as a gift | 6,650 | - |
| June 10, 2026 | Mccallister Michael BDirector | Gave as a gift | 1,209 | - |
| May 21, 2026 | Stetter MarkDirector | Exercised options | 1,572 | - |
| May 20, 2026 | Parent Louise MDirector | Exercised options | 1,944 | - |
| May 20, 2026 | Parent Louise MDirector | Exercised options | 10,186 | - |
| May 13, 2026 | Bisaro PaulDirector | Bought | 2,000 | $151.8K |
Who owns ZTS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 7.17% | April 30, 2026 |
| Vanguard Portfolio Management13G, passive | 5.7% | April 29, 2026 |
Largest institutional holders
Insiders
19 insiders reported holding 283,414 shares in total, about $23.5M at the last price.
| Holder | Shares |
|---|---|
| Peck Kristin CChief Executive Officer, Director | 105,068 |
| Parent Louise MDirector | 28,394 |
| Bisaro PaulDirector | 27,862 |
| Mccallister Michael BDirector | 24,52424,524 held indirectly |
| Joseph WettenyChief Financial Officer | 22,113 |
| Lagano RoxanneExecutive Vice President | 15,632 |
| Damelio Frank ADirector | 14,808 |
| Reed Willie MDirector | 12,864 |
| Driscoll RimmaExecutive Vice President | 5,715 |
| Leatherberry Antoinette ReneeDirector | 5,280 |
Questions about ZTS
What does Zoetis Inc. do?
Zoetis Inc. is a company in the Health care sector, listed on NYSE as ZTS. Its shares trade on NYSE under the ticker ZTS.
What is Zoetis Inc.'s net worth?
Zoetis Inc. has a market value (market cap) of $34.2B at the latest share price, and shareholders' equity of $3.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Zoetis Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $2.5B on revenue of $9.5B, a net margin of 26.4%.
How much revenue does Zoetis Inc. make?
Over the twelve months to September 30, 2026 Zoetis Inc. reported revenue of $9.5B. That is 0.9% more than a year earlier.
When did Zoetis Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Zoetis Inc.'s next earnings report?
Zoetis Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Zoetis Inc. pay a dividend?
Yes. Zoetis Inc. paid dividends of $2.03 per share in fiscal 2025, a yield of 2.45% at the current price.
Similar companies
Compare ZTS with
Follow ZTS
Get an email when Zoetis Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Zoetis Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.